Distributed Computing is Alive and Well on Pharma Desktops Despite Some Licensing and Tech Glitches | GenomeWeb

When distributed computing emerged as a viable high-performance computing option in the late 1990s, a number of vendors pegged the life sciences sector as a prime candidate for whole-hearted adoption of the approach.

While those early predictions may have been overly optimistic — many of those vendors are no longer in business — a number of IT managers in pharma and academia are finding that the approach does indeed offer a number of benefits over clusters and other computing options, provided that users are willing to grapple with a few unresolved issues.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.